Clinical Review - Renal colic
Contributed by Mr Ranan DasGupta, specialist registrar and Mr Jonathon Olsburgh, consultant urologic... Read more
Disease management programs were initially advocated by pharmaceutical companies in the1990s to provide value-added services to differentiate their drugs. When managed care organizations and outsourcing companies realised the potential of these programs to enhance patient management and reduce costs, they expanded the focus on specific diseases.
Software such as Dawn Rheumatology (RH)—which is manufactured by 4S Information Systems Ltd.— is an important resource for clinicians seeking a better way to manage their patients’ medicine and treatment. For example, Anti-TNF drugs for the treatment of rheumatoid arthritis are expensive and their effectiveness needs close monitoring. Fulfillment of American College of Rheumatology (ACR) 50–70% improvement and European League Against Rheumatism (EULAR) good response or remission [28-joint disease activity score (DAS28) <2.6] at three months are good outcome measures, according to Stewart.
“Dawn Rheumatology software has an integrated calculator/questionnaire module that can quickly derive these measures,” Stewart said. “The software has reports that permit ready tracking of these outcome measures such that it is easy to determine each patient's response with time."
Dawn RH was specially developed for the management of patients suffering from rheumatologic disorders relating to the loco-motor system, including joints, muscles, connective tissues, and soft tissues around the joints and bones. With Dawn RH, rheumatologists can implement a safer, more organised way to manage patients and achieve better outcomes.
The software is easy to use, yet comprehensive, and it can be integrated with other information systems such as laboratory and patient administration. In addition, Dawn RH includes useful features such as scheduling dietary notes, self assessment forms, results monitoring and audit. Using Dawn RH to electronically monitor patients offers a number of benefits for clinicians and their patients. For instance, physicians can:
While the use of clinical software is a growing trend, Dawn RH has been on the market for almost a decade. It has been used to treat thousands of UK patients at leading healthcare facilities such as St. Mary’s Hospital in London and Newcastle General Hospital in Newcastle-upon-Tyne. The software was recently introduced to the North American market.
Based in North West England, 4S Information Systems is a leading manufacturer of software for the health care industry. The company also offers anticoagulation management, anaemia patient tracking and hematology patient tracking software. Trading under the name 4S Dawn Clinical Software, the company maintains a staff of 14 and more than 300 customers in almost 20 different countries.
To learn more about how 4S Information Systems and Dawn RH are helping physicians leverage technology to improve patient care, please visit www.4s-dawn.com/dmard. Or contact Syd Stewart, managing director of 4S Information Systems Ltd., at 44 15395 63091.
Quick search - use * for an abbreviated search, eg nico*
Contributed by Mr Ranan DasGupta, specialist registrar and Mr Jonathon Olsburgh, consultant urologic... Read more
By Dr Helen Hosker, GP and clinical commissioning lead for stroke, NHS Manchester, and Dr Pippa Tyrr... Read more
Although it is one of the most common autoimmune diseases, Sjogren's syndrome remains underdiagnosed... Read more
The GPC has demanded a 4% rise in GMS income for 2009/10 to combat soaring expenses and inflation. Read more
The GPC has published an online calculator to allow practices to work out if they will be winners or... Read more
PCTs should interfere less in practice-based commissioning (PBC), the NHS chief executive has warned... Read more
Children born four months before peak flu season have a greater risk of developing asthma than those... Read more
Defibrillators manufactured by Medtronic may fail to work because of a faulty internal cable, the Me... Read more
Janssen-Cilag has launched Intelence (etravirine) for the treatment of HIV infection in antiretrovir... Read more
Janssen-Cilag has launched Doribax (doripenem) for the treatment of nosocomial pneumonia (including ... Read more
Ebixa (memantine) is now licensed for once-daily administration in the treatment of patients with mo... Read more
Comments
Only registered users may comment. Log in now or register for a free account.